Ledger.Open graph →

SEC Form D · filed January 2, 2024

Omnipulse Biosciences, Inc

Offering

$12.5M

Sold

$7.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Cambridge, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Robert Langer · Bedford, MADirector · Promoter Ana Jacklenec · Cambridge, MADirector · Promoter David Zhu · Boston, MADirector Robert Farra · Cambridge, MAExec · Director Joseph Desimone · Cary, NCPromoter Felicia Hsu · Cambridge, MADirector Robert Langer · PITTSBURGH, PADirector · Promoter Ana Jacklenec · Cambridge, MADirector · Promoter David Zhu · Boston, MADirector Robert Farra · Cambridge, MAExec · Director Joseph Desimone · Cary, NCPromoter Felicia Hsu · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗